Fundación Gecp
Clinical trials sponsored by Fundación Gecp, explained in plain language.
-
Blood tests track lung cancer drug effectiveness
Disease control OngoingThis study is testing how well the drug brigatinib works for people with advanced non-small cell lung cancer that has a specific genetic change (ALK+). Researchers will also explore if simple blood tests (liquid biopsies) can help track how the cancer responds to treatment over t…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Blood test could predict lung cancer survival after treatment
Knowledge-focused OngoingThis study aims to learn if a simple blood test can help predict how well patients with a specific stage of lung cancer will do after treatment. It will observe 100 patients in Spain who have stage IIIA non-small cell lung cancer and are scheduled to receive treatment before surg…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC